BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 36 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,026,143 | -18.7% | 3,871,291 | 0.0% | 0.44% | +28.9% |
| Q2 2023 | $4,955,252 | -7.9% | 3,871,291 | 0.0% | 0.34% | -8.3% |
| Q1 2023 | $5,381,094 | +106816.2% | 3,871,291 | 0.0% | 0.37% | -35.6% |
| Q4 2022 | $5,033 | -99.9% | 3,871,291 | 0.0% | 0.58% | -8.5% |
| Q3 2022 | $5,730,000 | -27.4% | 3,871,291 | 0.0% | 0.63% | -20.2% |
| Q2 2022 | $7,897,000 | -25.5% | 3,871,291 | 0.0% | 0.79% | +8.6% |
| Q1 2022 | $10,607,000 | -44.1% | 3,871,291 | 0.0% | 0.73% | -36.2% |
| Q4 2021 | $18,969,000 | -61.3% | 3,871,291 | 0.0% | 1.14% | -48.0% |
| Q3 2021 | $48,972,000 | -18.2% | 3,871,291 | 0.0% | 2.20% | -15.1% |
| Q2 2021 | $59,850,000 | -53.0% | 3,871,291 | 0.0% | 2.59% | -42.1% |
| Q1 2021 | $127,404,000 | – | 3,871,291 | – | 4.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $23,927,000 | 8.46% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $14,762,000 | 4.72% |
| Novo Holdings A/S | 4,503,991 | $56,975,000 | 2.95% |
| Vivo Capital, LLC | 3,871,291 | $48,972,000 | 2.20% |
| Sofinnova Investments, Inc. | 2,754,437 | $34,844,000 | 2.06% |
| Samsara BioCapital, LLC | 737,459 | $9,329,000 | 1.46% |
| Ally Bridge Group (NY) LLC | 257,267 | $3,254,000 | 0.96% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $9,102,000 | 0.68% |
| Rock Springs Capital Management LP | 1,649,248 | $20,863,000 | 0.44% |
| RA Capital Management | 2,378,325 | $30,086,000 | 0.42% |